文献
J-GLOBAL ID:201602241292572842
整理番号:16A0760019
ROS1+進行非小細胞肺癌(NSCLC)の東アジア人患者におけるクリゾチニブの第II相試験
A phase II study of crizotinib in East Asian patients with ROS1+ advanced non-small cell lung cancer (NSCLC)
著者 (10件):
SETO Takashi
(National Kyushu Cancer Center, Fukuoka, JPN)
,
YANG James CH
(National Taiwan Univ. Hospital and National Taiwan Univ. Cancer Center, Taipei, TWN)
,
WU Yi-Long
(Guangdong General Hospital & Guangdong Acad. of Medical Sci., Guangzhou, CHN)
,
KIM Dong-Wan
(Seoul National Univ. Hospital, Seoul, KOR)
,
YAMAMOTO Noboru
(National Cancer Center Hospital, Tokyo, JPN)
,
TAKAHASHI Toshiaki
(Shizuoka Cancer Center, Shizuoka, JPN)
,
YAMANAKA Takeharu
(Yokohama City Univ. School of Medicine, Yokohama, JPN)
,
KEMNER Allison
(OxOnc Dev., LP, NJ)
,
PAOLINI Jolanda
(Pfizer Oncology, Milan, ITA)
,
GOTO Koichi
(National Cancer Center Hospital East, Kashiwa, JPN)
資料名:
日本臨床腫瘍学会学術集会(CD-ROM)
(Program and Abstracts. Annual Meeting of Japanese Society of Medical Oncology (CD-ROM))
巻:
14th
ページ:
ROMBUNNO.O2-3-4
発行年:
2016年
JST資料番号:
L7804B
資料種別:
会議録 (C)
記事区分:
会議録記事
発行国:
日本 (JPN)
言語:
英語 (EN)